Vivos (RDGL) Long-Term Deferred Tax (2014)

Vivos' (RDGL) quarterly Long-Term Deferred Tax came in at -$7.8 million in Q4 2014.

Vivos (RDGL) Long-Term Deferred Tax (2014) Analysis & Trends

Vivos has disclosed Long-Term Deferred Tax across 1 years of filings, most recently posting -$7.8 million for Q4 2014.

Long-Term Deferred Tax for Q4 2014 came in at -$7.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was -$7.8 million (changed N/A YoY), and the FY2014 annual result was -$7.8 million, changed N/A from the prior year.
Long-Term Deferred Tax came in at -$7.8 million for Q4 2014 at Vivos.
In the past five years, Long-Term Deferred Tax ranged from a high of -$7.8 million in Q4 2014 to a low of -$7.8 million in Q4 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Vivos	-	-	-3,105.00

Download Data

Date	Value
Dec 31, 2014	-7.77 Mn